The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Elon Musk has suggested reality as we know it may be a simulation — a world that is not truly real.
One analyst thinks Tesla investors may be stuck in a world that is not real at all.
Barclay's analyst and longtime Tesla bear Brian Johnson published a research note Thursday called "Red-pilling the Tesla bull case" where he counters what he sees as several "articles of faith" in the Tesla bull case that are unmoored from fact.
To make his point, Johnson draws on a plot point from the "Matrix" films, where characters choose between swallowing a red pill, which will awaken them to the true horrors of their world, or a blue pill, which will return their minds to a state of blissful delusion inside a computer simulation.
The report runs more than 20 pages, but here are highlights, with the bull case "articles of faith" in quotes, followed by Johnson's view, paraphrased.
Still, investors seem to prefer the "blue pill," Johnson writes. He thinks the company's stock price — recently at an all-time high, and hovering around $300 Thursday — is driven by momentum and not the company's fundamentals. And he does not see anything in the near future that will reverse the stock's momentum.
"Barring a major sell-off in some of the high-value tech companies, the only thing that could send shares down over the next few months is something major happening with the Model 3 launch," Johnson said Thursday on CNBC's "Power Lunch. "
Still, Johnson maintains a $165 price target on the stock, which would represent an almost 50 percent drop from where the stock sits today.
Tesla was not immediately available for comment.
Others have argued that Tesla's share price reflects the company's potential. Musk said as much in a tweet Monday.
Some analysts see further prospects for Tesla beyond electric cars. For example, in a note published Wednesday, Morgan Stanley's Adam Jonas outlined several trillion-dollar markets Tesla could conceivably enter to further its growth.
On Thursday, S&P removed Tesla from its CreditWatch Negative list, meaning that while the firm's outlook on Tesla is still negative, the electric carmaker is no longer at risk of a ratings cut.